Eliel Bayever
- Co-authors
- Patrick L. IversenMark ArnesonRaymond W. RuddonCharles S. AugustAnne KessingerMichael BishopJamés O. ArmitageGerald Zon
- Topics
- Sarcoma Diagnosis and Treatment (11 papers)Cancer-related Molecular Pathways (9 papers)Cancer therapeutics and mechanisms (8 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- United StatesGermanySpain
In The Last Decade
Eliel Bayever
67 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 490
- Oncology 350
- Hematology 288
- Physiology 184
- Pulmonary and Respiratory Medicine 164
Countries citing papers authored by Eliel Bayever
This map shows the geographic impact of Eliel Bayever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eliel Bayever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eliel Bayever more than expected).
Fields of papers citing papers by Eliel Bayever
This network shows the impact of papers produced by Eliel Bayever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eliel Bayever. The network helps show where Eliel Bayever may publish in the future.
Co-authorship network of co-authors of Eliel Bayever
This figure shows the co-authorship network connecting the top 25 collaborators of Eliel Bayever. A scholar is included among the top collaborators of Eliel Bayever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eliel Bayever. Eliel Bayever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 36 | |
| 4 | 19 | |
| 5 | 134 | |
| 6 | 22 | |
| 7 | 16 | |
| 8 | 41 | |
| 9 | 61 | |
| 10 | 0 | |
| 11 | 21 | |
| 12 | 20 | |
| 13 | 119 | |
| 14 | Survival in Hurler's disease following bone marrow transplantation in 84 patients | 14 |
| 15 | 5 | |
| 16 | 40 | |
| 17 | 18 | |
| 18 | 59 | |
| 19 | 9 | |
| 20 | 40 |
About Eliel Bayever
Eliel Bayever is a scholar working on Hematology, Oncology and Biotechnology, having authored 69 papers that have together received 1.3k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (11 papers), Cancer-related Molecular Pathways (9 papers) and Cancer therapeutics and mechanisms (8 papers). The work is most often cited by research in Hematology (288 citations), Genetics (139 citations) and Oncology (350 citations). Eliel Bayever has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Patrick L. Iversen, Mark Arneson, Raymond W. Ruddon, Charles S. August, Anne Kessinger, Michael Bishop, Jamés O. Armitage, Gerald Zon, J. Jeffrey Malatack and Samuel J. Pirruccello. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.